Home» Circulars» Executive Training On Drug Development And Regulatory Affairs During 7 8th Dec.2019 At Dr.reddy’s Institute Of Life Sciences At University Of Hyderabad Campus Back
 
Executive Training on Drug Development and Regulatory Affairs during 7-8th Dec.2019 at Dr.Reddy’s Institute of Life Sciences at University of Hyderabad Campus
 


PxlNwLtrHeaderLogo

 

PXL/HO/Cir-086/2019-20                                                                      Dt: 05.12.2019

Hyderabad

 

 

 

Dear Sir/Madam,

 

 

 

Subject: Executive Training on Drug Development and Regulatory Affairs during 7-8th Dec.2019 at Dr.Reddy’s Institute of Life Sciences at University of Hyderabad Campus.

 

We would like to inform member companies that Manipal Academy of Higher Education (MAHE) in collaboration with European Centre of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland with support from Dr.Reddy’s Institute of Life Sciences(DRILS), Hyderabad  is organising a two-day Executive Training on “Drug Development and Regulatory Affairs” during 7-8th Dec.2019.

 

The European Centre of Pharmaceutical Medicine (ECPM) is the leading university institute for medicines and drug development in Europe. Experts representing the European Centre of Pharmaceutical Medicine and the University of Basel will be conducting a two-day session and their goal is to provide information about the process of drug development and the regulatory landscape, especially in the context of Europe. The expert faculty include

 

·   Prof Dr.Helmut Brand, Director, Jean Monnet Professor of European Public Health and Head of  

·   the Department of International Health at Maastricht University, Netherlands

·   Dr.Annette Mollet, Managing Director of European Centre of Pharmaceutical Medicine (ECPM)

·   Dr.Lada Leyens, Head of the Centre of Regulatory Affairs MAHE and Regulatory Manager,

·   European Program Lead at Roche, Basel, Switzerland.

 

The information of modules covered during the programme are as follows:

 

Module 1

Global Drug Research & Development and the Pharmaceutical Business Environment

Module 2

Finding a New Drug and the Transition from Animal into Human Body

Module 3

Safety Concepts & Personalised Treatment

Module 4

Clinical Trials and Data Management

Module 5

Global Registration and Market Access

Module 6

Trends and Innovative Tools

 

 

Who can attend: The programme is designed for Regulatory, Clinical and Drug Development professionals.

 

Registration:DRILS have requested Pharmexcil to nominate 20 delegates as complimentary registration. Each company can nominate one delegate for this programme. Member companies interested in registering the programme are requested to email at kiranamc@drils.org. Registration confirmation is done by the DRILS and is based on first-cum-first serve basis.  

 

 

With regards,

 

 

Uday Bhaskar
Director General